|
1
|
Nishimura M, Nagaharu K, Ikejiri M, Sugimoto Y, Sasao R, Ohya E, Mizutani M, Ohishi K, Tawara I, Sekine T. Acquisition of JAK2 V617F to CALR-mutated clones accelerates disease progression and might enhance growth capacity. Br J Haematol 2021; 194:e89-e92. [PMID: 34060068 DOI: 10.1111/bjh.17571] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Misa Nishimura
- Department of Hematology and Oncology, Matsusaka Chuo General Hospital, Matsusaka, Mie, Japan
| | - Keiki Nagaharu
- Department of Hematology and Oncology, Mie University Graduate School of Medicine/Faculty of Medicine, Tsu, Mie, Japan
| | - Makoto Ikejiri
- Central Laboratory Department, Mie University Hospital, Tsu, Mie, Japan
| | - Yuka Sugimoto
- Department of Community Hematology, Mie University Faculty of Medicine, Takeuchi Hospital, Tsu, Mie, Japan
| | - Ryota Sasao
- Department of Hematology and Oncology, Matsusaka Chuo General Hospital, Matsusaka, Mie, Japan
| | - Eiko Ohya
- Department of Hematology and Oncology, Matsusaka Chuo General Hospital, Matsusaka, Mie, Japan
| | - Minoru Mizutani
- Department of Hematology and Oncology, Matsusaka Chuo General Hospital, Matsusaka, Mie, Japan
| | - Kohshi Ohishi
- Transfusion Medicine and Cell Therapy, Mie University Hospital, Tsu, Mie, Japan
| | - Isao Tawara
- Department of Hematology and Oncology, Mie University Graduate School of Medicine/Faculty of Medicine, Tsu, Mie, Japan
| | - Takao Sekine
- Department of Hematology and Oncology, Matsusaka Chuo General Hospital, Matsusaka, Mie, Japan
| |
Collapse
|